ARPANSA issues ‘licence to operate’ for ANSTO’s Mo-99 facility
ARPANSA’s CEO, Dr Carl-Magnus Larsson has issued a licence to the Australian Nuclear Science and Technology Organisation (ANSTO) to operate the ANSTO Nuclear Medicine Molybdenum-99 (Mo-99) Facility (the ANM Facility).
Report to Parliament - Radiation exposure of a worker at ANSTO Health, Lucas Heights on 22 August 2017
The matter considered in this report is a radiation exposure of a worker on 22 August 2017 at the Australian Nuclear Science and Technology Organisation (ANSTO) Health radiopharmaceuticals production facility at Lucas Heights, NSW, which exceeded the relevant statutory dose limit.
Radiation exposure of a worker at ANSTO Health – report to Parliament
On Monday 26 February 2018 a report by the CEO of ARPANSA, Dr Carl-Magnus Larsson, was tabled in Parliament addressing the radiation exposure of a worker at the Australian Nuclear Science and Technology Organisation (ANSTO) Health radiopharmaceuticals production facility at Lucas Heights.
